华润三九_2024 年业绩及 2025 年展望 —— 在当前环境下总体仍是一项稳健投资

更多资料加入知识星球：水木调研纪要 关注公众号：水木Alpha Sean.Wu@morganstanley.com +852 3963-0755 March 17, 2025 04:01 AM GMT March 17, 2025 04:34 AM GMT China Resources Sanjiu Medical & Pharma | Asia Pacific On 2024 Results and 2025 Outlook - Overall Still a Safe Investment in the Current Environment Key Takeaways We point out two other dynamics as the year progresses. First, the current flu season is delayed compared to the last one, with a majority of incidence falling on 1Q instead of 4Q. So we expect Sanjiu's flu series sales ...